Days of plenty are over for biomedical research

01/3/2013 | Xconomy

As NIH funding for biomedical research has dwindled, scientists are turning to big drugmakers and disease-focused foundations, shifting the focus from basic to translational research, writes Luke Timmerman. The result could be a slew of new drugs, devices and diagnostics over the next decade, he writes. But moving too far away from basic research could bring missed opportunities for "a whole series of bigger breakthroughs that can come only from asking basic, open-ended research questions about how genes, cells, and lower organisms work," he writes.

View Full Article in:

Xconomy

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Executive Vice President-MyHealth First Network
Greenville Health System
Greenville, SC
Healthcare Compliance Manager
Ernst & Young
Multiple Locations, SL_Multiple Locations
Chief Medical Officer
VANDERBILT HEALTH AFFILIATE NETWORK
Nashville, TN
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Assistant General Counsel - Pharmaceutical R&D
GlaxoSmithKline
Multiple Locations, SL_Multiple Locations